This course provides an integrated view of how corporate strategy is delivered through the portfolio of new and lifecycle drug projects. Set in a small group setting, this highly interactive course uses a case study approach to help attendees develop real-world skills in building viable portfolio, strategy, and drug value processes.
COURSE HIGHLIGHTS
鈥tandard processes for portfolio, strategy, and drug value management.
鈥ow to translate generic processes into pragmatic and viable processes.
鈥rganizational approaches to drug value creation.
COURSE HIGHLIGHTS
鈥tandard processes for portfolio, strategy, and drug value management.
鈥ow to translate generic processes into pragmatic and viable processes.
鈥rganizational approaches to drug value creation.
